article · Rhinology Journal
The first European Rhinology Research Forum gathered 130 medical specialists, researchers, patients, and industry representatives across 27 countries to evaluate care pathways and research priorities for rhinitis and rhinosinusitis. The collaborative sessions examined current clinical practices, reviewing their existing strengths and limitations. Participants identified vital research priorities framed within the principles of precision medicine to enhance standard care. These priorities focus on delivering personalised care, predicting treatment success, actively involving patients in their care pathways, and implementing measures for disease prevention. The resulting consensus outlines key directions intended to update clinical approaches and guide future investigation in airway disease management.
Rhinitis and rhinosinusitis affect patient well-being, yet existing clinical practices face limitations. Aligning clinicians, researchers, patients, and industry on clear research targets encourages the development of precision medicine. Focusing on personalised treatment, prevention, and patient participation helps direct future healthcare strategies towards more predictable, effective care pathways for airway conditions.
The abstract does not report specific technologies, but it sets priority directions for industry and clinical researchers developing precision medicine tools for rhinitis and rhinosinusitis. Potential applications include diagnostic or predictive tools to forecast treatment success and personalised therapy regimes. These concepts reflect early-stage agenda setting and consensus building, meaning any direct products or therapies resulting from these identified needs remain at an early research stage.
AI-generated from the published abstract. Always read the original work before citing.
The first European Rhinology Research Forum organized by the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) was held in the Royal Academy of Medicine in Brussels on 17th and 18th November 2016, in collaboration with the European Rhinologic Society (ERS) and the Global Allergy and Asthma European Network (GA2LEN). One hundred and thirty participants (medical doctors from different specialties, researchers, as well as patients and industry representatives) from 27 countries took part in the multiple perspective discussions including brainstorming sessions on care pathways and research needs in rhinitis and rhinosinusitis. The debates started with an overview of the current state of the art, including weaknesses and strengths of the current practices, followed by the identification of essential research needs, thoroughly integrated in the context of Precision Medicine (PM), with personalized care, prediction of success of treatment, participation of the patient and prevention of disease as key principles for improving current clinical practices. This report provides a concise summary of the outcomes of the brainstorming sessions of the European Rhinology Research Forum 2016.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4193/rhin17.028
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
